These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 30257801)

  • 1. Anti-inflammatory therapy in well controlled HIV infection.
    Tarr PE; Calmy A
    Lancet HIV; 2018 Oct; 5(10):e538-e539. PubMed ID: 30257801
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis.
    Elliott AM; Luzze H; Quigley MA; Nakiyingi JS; Kyaligonza S; Namujju PB; Ducar C; Ellner JJ; Whitworth JA; Mugerwa R; Johnson JL; Okwera A
    J Infect Dis; 2004 Sep; 190(5):869-78. PubMed ID: 15295690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double-blind, randomised clinical trial.
    Newberry L; O'Hare B; Kennedy N; Selman A; Omar S; Dawson P; Stevenson K; Nishihara Y; Lissauer S; Molyneux E
    Paediatr Int Child Health; 2017 May; 37(2):121-128. PubMed ID: 28145162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nevirapine: a new principle of action against HIV].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A48-9. PubMed ID: 8998915
    [No Abstract]   [Full Text] [Related]  

  • 5. Kallistatin levels in HIV-infected patients and effects of statin therapy.
    Eckard AR; Cho S; O'Riordan MA; McComsey GA
    Biomarkers; 2017 Feb; 22(1):55-62. PubMed ID: 27326658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for HIV-related inflammation.
    Treat Rev; 1995 May; (no 18):11. PubMed ID: 11362590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers.
    Kim CJ; Rousseau R; Huibner S; Kovacs C; Benko E; Shahabi K; Kandel G; Ostrowski M; Kaul R
    AIDS; 2017 Jul; 31(11):1529-1534. PubMed ID: 28463882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study.
    Lindboe JB; Langkilde A; Eugen-Olsen J; Hansen BR; Haupt TH; Petersen J; Andersen O
    Infect Dis (Lond); 2016; 48(11-12):829-37. PubMed ID: 27417288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.
    Mayanja-Kizza H; Jones-Lopez E; Okwera A; Wallis RS; Ellner JJ; Mugerwa RD; Whalen CC;
    J Infect Dis; 2005 Mar; 191(6):856-65. PubMed ID: 15717259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
    Gallant JE; Koenig E; Andrade-Villanueva J; Chetchotisakd P; DeJesus E; Antunes F; Arastéh K; Moyle G; Rizzardini G; Fehr J; Liu Y; Zhong L; Callebaut C; Szwarcberg J; Rhee MS; Cheng AK
    J Infect Dis; 2013 Jul; 208(1):32-9. PubMed ID: 23532097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers.
    Francisci D; Falcinelli E; Baroncelli S; Petito E; Cecchini E; Weimer LE; Floridia M; Gresele P; Baldelli F
    Scand J Infect Dis; 2014 Jun; 46(6):466-70. PubMed ID: 24738757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection.
    Elion R; Cohen C; Gathe J; Shalit P; Hawkins T; Liu HC; Mathias AA; Chuck SL; Kearney BP; Warren DR;
    AIDS; 2011 Sep; 25(15):1881-6. PubMed ID: 21811136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial.
    Kaul R; Kimani J; Nagelkerke NJ; Fonck K; Ngugi EN; Keli F; MacDonald KS; Maclean IW; Bwayo JJ; Temmerman M; Ronald AR; Moses S;
    JAMA; 2004 Jun; 291(21):2555-62. PubMed ID: 15173146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine therapy in early HIV-1 infection using a recombinant canarypox virus expressing gp160MN (ALVAC-HIV): a double-blind controlled randomized study of safety and immunogenicity.
    Tubiana R; Gomard E; Fleury H; Gougeon ML; Mouthon B; Picolet H; Katlama C
    AIDS; 1997 May; 11(6):819-20. PubMed ID: 9143616
    [No Abstract]   [Full Text] [Related]  

  • 17. Piroxicam (CP 16171) in rheumatoid arthritis: a controlled clinical trial with novel assessment techniques.
    Weintraub M; Jacox RF; Angevine CD; Atwater EC
    J Rheumatol; 1977; 4(4):393-404. PubMed ID: 342691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Chocolate and Yerba Mate Phenolic Compounds on Inflammatory and Oxidative Biomarkers in HIV/AIDS Individuals.
    Petrilli AA; Souza SJ; Teixeira AM; Pontilho PM; Souza JM; Luzia LA; Rondó PH
    Nutrients; 2016 May; 8(5):. PubMed ID: 27223302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trial.
    Skowron G; Stein D; Drusano G; Melbourne K; Bilello J; Mikolich D; Rana K; Agosti JM; Mongillo A; Whitmore J; Gilbert MJ
    J Infect Dis; 1999 Oct; 180(4):1064-71. PubMed ID: 10479132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
    Lennox JL; DeJesus E; Lazzarin A; Pollard RB; Madruga JV; Berger DS; Zhao J; Xu X; Williams-Diaz A; Rodgers AJ; Barnard RJ; Miller MD; DiNubile MJ; Nguyen BY; Leavitt R; Sklar P;
    Lancet; 2009 Sep; 374(9692):796-806. PubMed ID: 19647866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.